Mr. Barry Balfe
CEO, ICON Pharma Development Solutions
Title: From Development Strategy to Global Clinical Execution: Building Effective Pharma Partnerships
International conference • Academic & industry participation • Limited to 120 participants
|
Dates: 20–22 January 2027
|
Venue: Singapore
Featured Speakers • Academia + Clinical Practice + Industry
ECTMBICS 2027 Featured Speakers
Meet keynote and invited speakers contributing scientific, clinical, and industry perspectives across translational medicine, biotechnology, pharmaceutical development, clinical research, genomics, digital health, and healthcare innovation.
Speaker programme
Curated leader sessions are designed for clinical insight, biotech strategy, institutional exchange, and healthcare innovation outcomes.
Congress dates
20–22 January 2027
Location
Singapore
Conference format
Keynotes + Oral + Posters
Business Address: 98 Theobalds Rd, London WC1X 8WB, UK
International speaker sessions
Keynotes • scientific dialogue • clinical perspectives • biotech innovation
Home
/
Featured Speakers
View Programme →
Note: Session order and final programme timings will be updated closer to the congress dates.
Featured Speakers
Senior clinical, translational, and industry leaders shaping evidence generation, implementation pathways, biotech strategy, and patient impact.
Prof. Han-Chung Wu
Biomedical Translation Research Center (BioTReC), Taiwan
Title: Advancing Biomedical Translation from Discovery Platforms to Clinical Applications
Matthew Hewitt
Charles River Laboratories
Title: Preclinical Models and Translational Pathways for Next-Generation Therapeutics
Prof. Lani Wu
University of California, San Francisco
Title: Systems-Level Approaches to Translational Medicine and Biomedical Discovery
Dr. Feng-Chi Chen
Institute of Population Health Sciences, National Health Research Institutes
Title: Population Health Evidence and Implementation Pathways for Clinical Translation
Marc Goemans
Chief Commercial Officer, Bora Biologics
Title: Biologics Manufacturing, Commercial Strategy and Global Partnership Models
Dr. Guillermo Del Angel
Center for Genomics Research, AstraZeneca
Title: Genomics-Driven Precision Medicine: Translating Data into Therapeutic Insight
Ed Deng
Co-Founder and CEO, Health2Sync
Title: Digital Health Platforms for Patient Engagement, Monitoring and Clinical Outcomes
Sanghoon Park
CEO, Illimis Therapeutics, Korea
Title: Therapeutics Innovation and Biotech Leadership in Emerging Clinical Pipelines
Important
ECTMBICS 2027 is intentionally limited to approximately 120 participants to support high-quality scientific discussion, closer interaction with speakers, and meaningful international networking.